| Title | Date | PubMed ID |
|---|
| Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3. | 2015 Sep 1 | 26277760 |
| Reprint of "In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3". | 2015 Sep | 26291835 |
| Structures of complexes of type 5 17β-hydroxysteroid dehydrogenase with structurally diverse inhibitors: insights into the conformational changes upon inhibitor binding. | 2015 Apr | 25849402 |
| Isoquinoline alkaloids as a novel type of AKR1C3 inhibitors. | 2014 Sep | 24769118 |
| Synthesis of 3-spiromorpholinone androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3. | 2013 Dec 1 | 24144853 |
| Synthesis and structure-activity relationships for 1-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-ones as novel non-carboxylate inhibitors of the aldo-keto reductase enzyme AKR1C3. | 2013 Apr | 23454516 |
| 2,3-Diarylpropenoic acids as selective non-steroidal inhibitors of type-5 17β-hydroxysteroid dehydrogenase (AKR1C3). | 2013 Apr | 23353746 |
| Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers. | 2013 Feb 25 | 23165153 |
| The microsomal enzyme 17β-hydroxysteroid dehydrogenase 3 faces the cytoplasm and uses NADPH generated by glucose-6-phosphate dehydrogenase. | 2013 Jan | 23183177 |
| N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3. | 2012 Sep 15 | 22897946 |